scholarly journals Association Between Urinary Albumin Excretion and Plasma 5-Hydroxyindole-3-Acetic Acid Concentration in Men With Type 2 Diabetes

Diabetes Care ◽  
2007 ◽  
Vol 30 (10) ◽  
pp. 2649-2651 ◽  
Author(s):  
M. Fukui ◽  
H. Ose ◽  
G. Hasegawa ◽  
T. Yoshikawa ◽  
N. Nakamura
Keyword(s):  
Type 2 Diabetes ◽  
Acetic Acid ◽  
Acid Concentration ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Acetic Acid Concentration ◽  
Albumin Excretion

scholarly journals Association Between Urinary Albumin Excretion and Serum Dehydroepiandrosterone Sulfate Concentrations in Women With Type 2 Diabetes

Diabetes Care ◽  
2007 ◽  
Vol 30 (7) ◽  
pp. 1886-1888 ◽  
Author(s):  
M. Fukui ◽  
H. Ose ◽  
I. Nakayama ◽  
H. Hosoda ◽  
M. Asano ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Urinary Albumin Excretion ◽  
Dehydroepiandrosterone Sulfate ◽  
Urinary Albumin ◽  
Albumin Excretion

scholarly journals Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study

2018 ◽  
Vol 2018 ◽  
pp. 1-5
Author(s):  
Hidenori Hirukawa ◽  
Shinji Kamei ◽  
Tomohiko Kimura ◽  
Atsushi Obata ◽  
Kenji Kohara ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Renal Function ◽  
Diabetic Nephropathy ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Albumin Excretion ◽  
Chronic Hyperglycemia ◽  
Retrospective Clinical Study ◽  
Japanese Subjects

It is very important to explore how we can reduce urinary albumin excretion which is an independent risk factor for ischemic heart disease. In this study, we retrospectively evaluated the effects of RAS inhibitor therapy on diabetic nephropathy in Japanese subjects whose urinary albumin levels were within normal range. We enrolled 100 subjects with type 2 diabetes who did not take any renin-angiotensin system (RAS) inhibitor. We defined the subjects taking RAS inhibitor for more than 3 years as RAS inhibitor group. RAS inhibitor exerted protective effect on the progression of urinary albumin excretion in subjects with type 2 diabetes without diabetic nephropathy. In addition, RAS inhibitor exerted more protective effects on renal function especially in subjects with poor glycemic control. In conclusion, RAS inhibitor could protect renal function against the deleterious effect of chronic hyperglycemia in Japanese subjects with type 2 diabetes even before the onset of diabetic nephropathy.

scholarly journals Relationship between Urinary Albumin Excretion and Left Ventricular Mass with Mortality in Patients with Type 2 Diabetes

2006 ◽  
Vol 1 (6) ◽  
pp. 1187-1190 ◽  
Author(s):  
Niloofar Nobakhthaghighi ◽  
Mohammed Kamgar ◽  
Mir R. Bekheirnia ◽  
Kim McFann ◽  
Raymond Estacio ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Left Ventricular Mass ◽  
Urinary Albumin Excretion ◽  
Left Ventricular ◽  
Urinary Albumin ◽  
Albumin Excretion ◽  
Ventricular Mass

Relationships between Heart Rate Variability and Urinary Albumin Excretion in Patients with Type 2 Diabetes

2006 ◽  
Vol 331 (2) ◽  
pp. 72-78 ◽  
Author(s):  
Kohzo Takebayashi ◽  
Rika Matsutomo ◽  
Sachiko Matsumoto ◽  
Mariko Suetsugu ◽  
Sadao Wakabayashi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Heart Rate ◽  
Heart Rate Variability ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Albumin Excretion

Apolipoprotein (a) Levels and Atherogenic Lipid Fractions in Relation to the Degree of Urinary Albumin Excretion in Type 2 Diabetes mellitus

Nephron ◽  
1994 ◽  
Vol 66 (3) ◽  
pp. 273-277 ◽  
Author(s):  
Christoph Schnack ◽  
Peter Pietschmann ◽  
Paul Knöbl ◽  
Elisabeth Schuller ◽  
Rudolf Prager ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Albumin Excretion ◽  
Apolipoprotein A ◽  
Lipid Fractions ◽  
Atherogenic Lipid
Sign in / Sign up

Export Citation Format

Share Document